What is the maximum recommended dosage of Metoprolol (beta-blocker) for treating hypertension and other indications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dosage of Metoprolol for Various Indications

The maximum recommended dosage of metoprolol tartrate is 200 mg daily for hypertension, while metoprolol succinate (extended-release) has a maximum daily dose of 400 mg. 1, 2, 3

Formulation-Specific Maximum Dosages

  • Metoprolol tartrate (immediate-release):

    • Hypertension: Maximum 200 mg daily, typically divided into two doses 1, 2
    • Usual dose range: 100-200 mg daily 1
    • Initial dose: 25-50 mg twice daily, with gradual titration 2
  • Metoprolol succinate (extended-release):

    • Maximum dose: 400 mg once daily 2
    • Usual dose range: 50-200 mg once daily 1
    • Mean dose achieved in heart failure trials: 159 mg daily 1

Indication-Specific Dosing

  • Hypertension:

    • Metoprolol tartrate: 100-450 mg daily has been shown effective in controlled studies 3
    • Most patients with mild to moderate hypertension can be controlled with once-daily dosing of extended-release formulation 4
  • Heart Failure:

    • Target dose: 200 mg once daily of metoprolol succinate 1
    • Initial dose: 12.5-25 mg once daily with gradual titration at 2-week intervals 5
    • Mean dose achieved in MERIT-HF trial: 159 mg daily 1
  • Myocardial Infarction:

    • Initial treatment: 50 mg every 6 hours for 48 hours following IV administration 3
    • Maintenance dose: 100 mg twice daily 3

Special Populations and Considerations

  • Hepatic impairment: Lower maximum doses are recommended due to decreased metabolism and prolonged elimination half-life (up to 7.2 hours) 3

  • Elderly patients: Lower initial doses are recommended due to potential decreased hepatic, renal, or cardiac function 3

  • Poor CYP2D6 metabolizers (approximately 8% of Caucasians): May require lower maximum doses due to higher plasma concentrations and longer half-life (7-9 hours) 3

  • Contraindications for metoprolol use include:

    • Signs of heart failure
    • Low output state
    • Increased risk for cardiogenic shock
    • PR interval >0.24 seconds
    • Second or third-degree heart block
    • Active asthma or reactive airways disease 2

Dose-Response Considerations

  • Studies suggest a relatively horizontal dose-response curve at doses above 200 mg/day, indicating limited additional benefit with higher doses 6

  • When initiating therapy, starting with low doses and gradually titrating upward is recommended to minimize adverse effects 2, 5

  • For patients not responding to metoprolol monotherapy, addition of a thiazide diuretic may provide better blood pressure control than further increasing metoprolol dose 4

Administration Guidelines

  • Avoid abrupt cessation of therapy to prevent rebound hypertension or worsening of angina 2

  • Monitor blood pressure, heart rate, and signs of worsening heart failure during dose titration 2

  • Target resting heart rate of 50-60 beats per minute unless limiting side effects occur 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metoprolol Treatment Protocol for Hypertension and Heart-Related Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Experiences with metoprolol Durules, a slow-release formulation in hypertension.

The Journal of international medical research, 1980

Research

Metoprolol kinetics and dose response in hypertensive patients.

Clinical pharmacology and therapeutics, 1980

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.